MedTrace Logo

Ketamine Versus Etomidate for Rapid Sequence Intubation

NCT01823328 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 143

Last updated 2019-05-24

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the effectiveness and safety of ketamine and etomidate during rapid sequence intubation (RSI).

Conditions

  • Airway Control
  • Anesthesia
  • Intubation
  • Complication

Interventions

DRUG

Ketamine

Subjects will receive ketamine for sedation prior to rapid sequence intubation.

DRUG

Etomidate

Subjects will receive etomidate for sedation prior to rapid sequence intubation.

Sponsors & Collaborators

  • Hennepin Healthcare Research Institute

    lead OTHER

Principal Investigators

  • Brian E Driver, MD · Hennepin County Medical Canter

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01823328 on ClinicalTrials.gov